Trial intelligence / Profile preview

Syntrillo Telehealth Service for Stroke Risk Reduction

NCT07124728Terminated

Sponsor
Syntrillo
Start
Jul 2025
Primary completion
Jul 2026
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Syntrillo. Primary endpoint: Change in Systolic Blood Pressure at 6 months. Started Jul 2025; status: terminated.

Beyond the preview

Go deeper on NCT07124728.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07124728.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call